Rebecca Cook

Array ( [id] => 4235423 [patent_doc_number] => 06117905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Edible oil containing arachidonic acid and foods containing the same' [patent_app_type] => 1 [patent_app_number] => 9/284205 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5974 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117905.pdf [firstpage_image] =>[orig_patent_app_number] => 284205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147159 [patent_doc_number] => 06063771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Formulations for controlling human lice' [patent_app_type] => 1 [patent_app_number] => 9/338116 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9215 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063771.pdf [firstpage_image] =>[orig_patent_app_number] => 338116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323544 [patent_doc_number] => 06331569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Preparation for improving hair growth, the skin structure and/or nail regeneration' [patent_app_type] => 1 [patent_app_number] => 9/101817 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3250 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331569.pdf [firstpage_image] =>[orig_patent_app_number] => 101817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288933 [patent_doc_number] => 06268396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Use of valproic acid analog for the treatment and prevention of migraine and affective illness' [patent_app_type] => 1 [patent_app_number] => 9/337986 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8043 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268396.pdf [firstpage_image] =>[orig_patent_app_number] => 337986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141709 [patent_doc_number] => 06060515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Treatment of skin conditions by use of PPAR.alpha. activators' [patent_app_type] => 1 [patent_app_number] => 9/101366 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 19 [patent_no_of_words] => 10855 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060515.pdf [firstpage_image] =>[orig_patent_app_number] => 101366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099522 [patent_doc_number] => 06048879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride' [patent_app_type] => 1 [patent_app_number] => 9/332196 [patent_app_country] => US [patent_app_date] => 1999-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7763 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048879.pdf [firstpage_image] =>[orig_patent_app_number] => 332196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384474 [patent_doc_number] => 06262118 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia' [patent_app_type] => 1 [patent_app_number] => 9/325997 [patent_app_country] => US [patent_app_date] => 1999-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16702 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262118.pdf [firstpage_image] =>[orig_patent_app_number] => 325997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699445 [patent_doc_number] => 07067545 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-27 [patent_title] => 'Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia' [patent_app_type] => utility [patent_app_number] => 09/719278 [patent_app_country] => US [patent_app_date] => 1999-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3164 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067545.pdf [firstpage_image] =>[orig_patent_app_number] => 09719278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360152 [patent_doc_number] => 06191168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Methods for the use of nonprotein amino acids as therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 9/324181 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191168.pdf [firstpage_image] =>[orig_patent_app_number] => 324181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272531 [patent_doc_number] => 06245803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Palatable elemental medical food' [patent_app_type] => 1 [patent_app_number] => 9/539029 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8477 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245803.pdf [firstpage_image] =>[orig_patent_app_number] => 539029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383904 [patent_doc_number] => 06277880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Chemical compounds' [patent_app_type] => 1 [patent_app_number] => 9/314894 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22134 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277880.pdf [firstpage_image] =>[orig_patent_app_number] => 314894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272225 [patent_doc_number] => 06245782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/312987 [patent_app_country] => US [patent_app_date] => 1999-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 10842 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245782.pdf [firstpage_image] =>[orig_patent_app_number] => 312987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086164 [patent_doc_number] => 06162833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Photostable aqueous solution comprising benzyl alcohol derivatives' [patent_app_type] => 1 [patent_app_number] => 9/292664 [patent_app_country] => US [patent_app_date] => 1999-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3278 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162833.pdf [firstpage_image] =>[orig_patent_app_number] => 292664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104262 [patent_doc_number] => 06100302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Propofol formulation with enhanced microbial characteristics' [patent_app_type] => 1 [patent_app_number] => 9/286159 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2534 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100302.pdf [firstpage_image] =>[orig_patent_app_number] => 286159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183524 [patent_doc_number] => 06020378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Method for selectively altering body fat level, feed efficiently, or weight gain' [patent_app_type] => 1 [patent_app_number] => 9/281382 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3227 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020378.pdf [firstpage_image] =>[orig_patent_app_number] => 281382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184155 [patent_doc_number] => 06150347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Use of aldosterone antagonists to inhibit myocardial fibrosis' [patent_app_type] => 1 [patent_app_number] => 9/281442 [patent_app_country] => US [patent_app_date] => 1999-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6427 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150347.pdf [firstpage_image] =>[orig_patent_app_number] => 281442 [rel_patent_id] =>[rel_patent_doc_number] =>)